M. Buonanno

Efficacy and safety of tofacitinib, an oral Janus kinase inhibitor, in the treatment of psoriasis: a Phase 2b randomized placebo-controlled dose-ranging study

Kim Papp, Alan Menter, Bruce Strober et al. · British Journal of Dermatology · 2012 · 328 citations

Tofacitinib, an oral Janus kinase inhibitor, for the treatment of chronic plaque psoriasis: results from two randomized, placebo-controlled, phase III trials

Kim Papp, Alan Menter, Mai Abe et al. · British Journal of Dermatology · 2015 · 310 citations · Full text

Effect of tofacitinib, a Janus kinase inhibitor, on haematological parameters during 12 weeks of psoriasis treatment

Bruce Strober, M. Buonanno, James D. Clark et al. · British Journal of Dermatology · 2013 · 94 citations

Tofacitinib improves pruritus and health-related quality of life up to 52 weeks: Results from 2 randomized phase III trials in patients with moderate to severe plaque psoriasis

Steven R. Feldman, Diamant Thaçi, Melinda Gooderham et al. · Journal of the American Academy of Dermatology · 2016 · 64 citations

Clinical Therapeutic, Health-related Quality, Clinical Trials +6

Bronchiolitis obliterans following pediatric allogeneic hematopoietic stem cell transplantation

C.N. Duncan, M. Buonanno, Elly Barry et al. · Bone Marrow Transplantation · 2008 · 58 citations

Asthma, Lung Transplantation, Transplantation +3